About
Focus
Pipeline
Investors
Contact
More
We advance innovative clinical research evaluating novel treatments for rare dermatologic diseases with limited options.
At our core, we focus on supporting people living with some of the most serious conditions in medical dermatology.
We are positioned to expand our clinical development programs to target broader conditions with these novel treatments in the years ahead.
Stay up to date with the latest news on Timber Pharmaceuticals (TMBR).
